# Comparison of Different Up-dosing Schedules With Osiris

> **NCT01240954** · PHASE2 · TERMINATED · sponsor: **ALK-Abelló A/S** · enrollment: 210 (estimated)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** OSIRIS
- **DRUG:** OSIRIS other concentration 1
- **DRUG:** OSIRIS other concentration 2

## Key facts

- **NCT ID:** NCT01240954
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 210 (ESTIMATED)
- **Why stopped:** CA approval not obtained
- **Last updated:** 2011-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01240954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01240954, "Comparison of Different Up-dosing Schedules With Osiris". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01240954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*